Psychotherapy combined with drug therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome: A randomized controlled trial

Wang, Jianxin; Liang, Kuixiang; Sun, Huijing; Li, Lianpeng; Wang, Hongcai; Cao, Ji

doi:10.1111/iju.13706

Cited by 18 publications

(9 citation statements)

References 29 publications

(53 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This abnormal psychology such as depression, anxiety, hostility, and compulsion will eventually make patients lose confidence in treatment. The symptoms of type III prostatitis are mainly located in the lower abdomen, perineum, and other parts [ 18 ]. It is very easy for patients to associate symptoms with sexual function, which further increases the psychological burden of patients and induces psychological problems [ 19 , 20 ].…”

Section: Discussionmentioning

confidence: 99%

Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience

Zhang

Cai

et al. 2022

Computational and Mathematical Methods in Medicine

View full text Add to dashboard Cite

Objective. UPOINT clinical phenotype system was used to estimate the type III prostatitis patients. Put in the erectile dysfunction (ED) domain and analysis the ED domain’s effect towards the UPOINT system. Methods. A total of 126 patients with type III prostatitis were prospectively collected and classified in each domain of the UPOINT system, including urinary, psychosocial, organ-specific, infection, neurological/systemic, and tenderness. Symptom severity was measured using the national institutes of health chronic prostatitis symptom index (NIH-CPSI) and the international prostate symptom score (IPSS). The erectile function was evaluated using the international index of erectile function (IIEF-5). Mental state was evaluated using the Symptom Checklist 90 (SCL-90). The quality of life of patients was assessed by the Quality of Life scale (QoL). Results. The percentage of patients positive for each domain was 60.32%, 43.65%, 53.17%, 11.11%, 42.06%, and 33.33% for the urinary, psychosocial, organ-specific, infection, neurological/systemic, and tenderness, respectively. There were significant correlations between the number of positive UPOINT domains and total NIH-CPSI ( r = 0.630 , P < 0.001 ) and IPSS ( r = 0.429 , P < 0.001 ). Symptom duration was associated with a number of positive domains ( r = 0.194 , P < 0.05 ). After adding an ED domain to establish a modified UPOINT system, the correlation between the number of positive domains and symptom severity was not improved (0.630 to 0.590, P < 0.001 ). The percentage of the patients who suffered psychosocial problems was 43.65%. Conclusions. In our cohort, the number of positive domains was correlated with symptom severity. Inclusion of the ED phenotype in the UPOINT phenotype classification system did not significantly enhance the association of positive presentation with symptom severity. Our findings presented do not support the utility of using ED as a stand-alone item in the UPOINT domain. Psychological problems should be considered when treating type III prostatitis patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience

Zhang

Cai

et al. 2022

Computational and Mathematical Methods in Medicine

View full text Add to dashboard Cite

show abstract

“…In their report, Wang et al . noted that CP/CPPS patients are more likely to have psychiatric symptoms than the general population, and assessment of severity with evaluation scales, such as the Self‐Rating Anxiety Scale and Self‐Rating Depression Scale, is important . However, it remains controversial whether the psychological intervention described in the present study is necessary for all patients with CP/CPPS symptoms.…”

mentioning

confidence: 89%

“…A recent review carried out in Europe showed the importance of a multimodal therapeutic approach for CP treatment; however, few studies of CP/CPPS have been carried out in Japan. Therefore, the present research results might be considered as reference findings for Japanese patients, as the study was carried out in Asia …”

mentioning

confidence: 91%

Editorial Comment to Psychotherapy combined with drug therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome: A randomized controlled trial

Togo¹

2018

Int J of Urology

View full text Add to dashboard Cite

“…Choroba obejmuje elementy fizyczne, emocjonalne i psychologiczne. Skuteczne leczenie musi zatem skupiać się nie tylko na fizycznej patologii, ale także na emocjonalnych i psychologicznych aspektach zaburzenia [9]. Stosuje się wiele różnych terapii, w tym leki przeciwzapalne, antybiotyki, alfa-blokery, modulatory bólu neuropatycznego, inhibitory 5α-reduktazy, psychoterapię [6] i fizjoterapię dna miednicy [10] .…”

Section: Wprowadzenieunclassified

Chronic Prostatitis / Chronic Pelvic Pain Syndrome – problematic common disease. Current knowledge on etiology, diagnosis and treatments

ŻOŁYNIAK¹,

ŻABA²,

WARZYSZAK³

et al. 2022

View full text Add to dashboard Cite

Introduction: Nonbacterial prostatitis (CNP) also known as chronic pelvic pain syndrome (CPPS) is a condition with an incompletely understood etiology. Chronic prostatitis is diagnosed when symptoms of prostatitis persist for more than 3 months and it is difficult to treat. The causes are not fully understood. Among the many possible causes are stress, psycho-emotional disorders, hormonal disorders and autoimmune disorders. The main symptom is pain usually felt in the perineum, at the base of the penis, in the anal area, sometimes over the pubic symphysis. This pain can radiate to the penis and scrotum. Aim of the study: Summary of current knowledge on the treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Material and methods: Review of PubMed articles using the following keywords: “nonbacterial chronic prostatitis”, “abacterial chronic prostatitis” and “chronic pelvic pain syndrome”. Results: Complete cure in non-bacterial chronic prostatitis is rare. Due to the lack of knowledge of the cause of chronic prostatitis, there is no effective treatment for this disease. Although the pathogen is rarely found in the patients studied, many patients show improvement after antibiotic therapy. In addition, anti-inflammatory drugs, alpha blockers and neuromodulators are used. Physical therapy also has proven benefits in relieving symptoms. Conclusion: CNP is a frustrating disease for many doctors and patients. Although it is not yet completely understood, we have made significant progress in the evaluation and treatment of this disease over the past several decades. Physicians need to move away from outdated algorithms that often result in endless courses of antibiotics and embrace multimodal therapy, which provides better results than other treatment strategies.

show abstract

Psychotherapy combined with drug therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome: A randomized controlled trial

Abstract: Psychological intervention therapy can effectively improve the psychological status and sexual function in patients with category III chronic prostatitis/chronic pelvic pain syndrome than the routine medication.

Cited by 18 publications

References 29 publications

Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience

Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience

Editorial Comment to Psychotherapy combined with drug therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome: A randomized controlled trial

Chronic Prostatitis / Chronic Pelvic Pain Syndrome – problematic common disease. Current knowledge on etiology, diagnosis and treatments

Contact Info

Product

Resources

About